Medical University of Warsaw
-
DATABASE (2789)
-
ARTICLES (812)
Caris LeVert is a professional basketball player in the USA’s National Basketball Association league, playing for the Brooklyn Nets. A graduate of the University of Michigan, he joined the Nets in 2016, after the Indiana Pacers swapped him for Thaddeus Young in that year’s draft. In 2019, the Nets signed a three year-extension for LeVert’s contract, worth $52.5m.LeVert is managed by Roc Nation, the entertainment and sports management firm founded by musician Jay-Z. He took part in Roc Nation’s investment (via venture arm Arrive) in Indonesian coffee brand Kopi Kenangan. LeVert is also the founder of the 22 Initiative, a youth mentorship program in New York.
Caris LeVert is a professional basketball player in the USA’s National Basketball Association league, playing for the Brooklyn Nets. A graduate of the University of Michigan, he joined the Nets in 2016, after the Indiana Pacers swapped him for Thaddeus Young in that year’s draft. In 2019, the Nets signed a three year-extension for LeVert’s contract, worth $52.5m.LeVert is managed by Roc Nation, the entertainment and sports management firm founded by musician Jay-Z. He took part in Roc Nation’s investment (via venture arm Arrive) in Indonesian coffee brand Kopi Kenangan. LeVert is also the founder of the 22 Initiative, a youth mentorship program in New York.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
CEO and Founder of Didimo
Argentinian-born Verónica Costa Orvalho is a veteran in animation technology. In 2016, she became the CEO and founder of Didimo that was inspired by an earlier venture Face In Motion, established in 2007 to focus on cinematic quality and animation production of faces. Orvalho won the award for the AI and virtual reality category at a Women Startup Challenge event held in New York in 2017. Orvalho has a long academic track record in related fields, beginning with a first degree in Software Engineering from the University of Belgrano in Buenos Aires. She moved to Barcelona and obtained a master's degree in Videogame Design and Development at University Pompeu Fabra where she continued to work on creating a facial animation system “For CG Films”. She later completed her PhD at the Polytechnic University of Catalonia with her thesis: Fast and Reusable Facial Rigging and Animation to develop an application that could speed up the traditional “slowing rigging” process. She has worked at Ericsson as a systems analyst and was a producer at the Argentinian film company Patagonik Film Group that helped to produce the Oscar-winning movie El hijo de la novia. She worked for four years as the founder of Panorama Consulting, a consultancy focusing on developing systems for the medical, logistics and entertainment industries. Since 2003, she has lectured in different institutions, including Porto University's Porto Interactive Center as its specialist in facial animation since 2008.
Argentinian-born Verónica Costa Orvalho is a veteran in animation technology. In 2016, she became the CEO and founder of Didimo that was inspired by an earlier venture Face In Motion, established in 2007 to focus on cinematic quality and animation production of faces. Orvalho won the award for the AI and virtual reality category at a Women Startup Challenge event held in New York in 2017. Orvalho has a long academic track record in related fields, beginning with a first degree in Software Engineering from the University of Belgrano in Buenos Aires. She moved to Barcelona and obtained a master's degree in Videogame Design and Development at University Pompeu Fabra where she continued to work on creating a facial animation system “For CG Films”. She later completed her PhD at the Polytechnic University of Catalonia with her thesis: Fast and Reusable Facial Rigging and Animation to develop an application that could speed up the traditional “slowing rigging” process. She has worked at Ericsson as a systems analyst and was a producer at the Argentinian film company Patagonik Film Group that helped to produce the Oscar-winning movie El hijo de la novia. She worked for four years as the founder of Panorama Consulting, a consultancy focusing on developing systems for the medical, logistics and entertainment industries. Since 2003, she has lectured in different institutions, including Porto University's Porto Interactive Center as its specialist in facial animation since 2008.
Well-known for co-founding JobsCentral in Singapore, Lim Der Shing has been an angel investor since 2009. JobsCentral was acquired by CareerBuilder USA in 2011 and Der Shing became its Asia-Pacific MD. He left the new role after six months in 2014 to become a full-time investor and partner at Singapore-based VC Jungle Ventures. The electrical and electronic engineer graduated in 1999 with a Summa cum Laude from the University of Michigan, USA. As a scholar, he returned to work at Sembcorp before co-founding JobsCentral’s predecessor JobsFactory in 2000 with co-founder and wife Huang Shao-Ning.
Well-known for co-founding JobsCentral in Singapore, Lim Der Shing has been an angel investor since 2009. JobsCentral was acquired by CareerBuilder USA in 2011 and Der Shing became its Asia-Pacific MD. He left the new role after six months in 2014 to become a full-time investor and partner at Singapore-based VC Jungle Ventures. The electrical and electronic engineer graduated in 1999 with a Summa cum Laude from the University of Michigan, USA. As a scholar, he returned to work at Sembcorp before co-founding JobsCentral’s predecessor JobsFactory in 2000 with co-founder and wife Huang Shao-Ning.
Brad Bao (Bao Zhoujia) graduated in International Marketing at Wuhan University in 1997 and obtained an MBA from UC Berkeley in 2005. He worked in marketing at FORMICA from January 1997 to March 1998 and went on to work at Kodak until April 2000. He was at IBM until April 2001 when he finally decided to become an entrepreneur and co-founded NORICT in Beijing.He was also the GM and VP of the US branch for Tencent from 2005–2012. He joined Kinzon Capital as managing partner in September 2013 and co-founded LimeBike in the US in November 2016.
Brad Bao (Bao Zhoujia) graduated in International Marketing at Wuhan University in 1997 and obtained an MBA from UC Berkeley in 2005. He worked in marketing at FORMICA from January 1997 to March 1998 and went on to work at Kodak until April 2000. He was at IBM until April 2001 when he finally decided to become an entrepreneur and co-founded NORICT in Beijing.He was also the GM and VP of the US branch for Tencent from 2005–2012. He joined Kinzon Capital as managing partner in September 2013 and co-founded LimeBike in the US in November 2016.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
Mayfield Fund is one of Silicon Valley's oldest venture capital firms. Founded by Wally Davis and Thomas J Davis Jr in 1969, the VC is based in Menlo Park, California.Current investments include CRISPR-focused companies like Mammoth Biosciences and biotech startup iLoF,l which is focused on creating a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.. With a total of $2.5bn assets under management, the firm focuses mainly on early-stage to growth-stage investments. The VC has also backed startups like Marketo, Lyft and SolarCity. Most of Mayfield’s exits took place during the 2008 financial crisis and through subsequent funds.In April 2020, amid the Covid-19 pandemic, Mayfield announced two new funds which raised $750m in total. Mayfield XVI will invest in early-stage companies, while Mayfield Select II will focus on growth-stage companies outside its portfolio. The company said last year that it has raised a similar size fund every four years and has invested in 30 companies per fund. It primarily leads Series A investments.
SkyDeck Berkeley is the startup accelerator initiated by the University of California, Berkeley. It was established to commercialize the university’s research arm and startup ventures of its alumni. It provides non-equity funding assistance, mentorship and networking opportunities, as well as specialist resources for not-for-profit ventures.Since 2012, SkyDeck-backed startups have raised total funding of over $1.47bn, with 17 achieving exits through acquisitions. The accelerator’s investment-arm is Berkeley SkyDeck Fund also invests about $100,000 per startup during the program. Half of the SkyDeck fund’s profits goes to UC Berkeley to support public education projects. The fund is run by Chon Tang as managing partner and Brian Bordley as principal. Contributors to the fund include private individuals, corporations and VCs like Sequoia Capital, Sierra Ventures and Canvas Ventures.
SkyDeck Berkeley is the startup accelerator initiated by the University of California, Berkeley. It was established to commercialize the university’s research arm and startup ventures of its alumni. It provides non-equity funding assistance, mentorship and networking opportunities, as well as specialist resources for not-for-profit ventures.Since 2012, SkyDeck-backed startups have raised total funding of over $1.47bn, with 17 achieving exits through acquisitions. The accelerator’s investment-arm is Berkeley SkyDeck Fund also invests about $100,000 per startup during the program. Half of the SkyDeck fund’s profits goes to UC Berkeley to support public education projects. The fund is run by Chon Tang as managing partner and Brian Bordley as principal. Contributors to the fund include private individuals, corporations and VCs like Sequoia Capital, Sierra Ventures and Canvas Ventures.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
One of the earliest and independent VC firms in China, Chengwei Capital was founded in Shanghai in 1999. It’s also the first and only evergreen fund in China.With Yale University Endowment as its largest investor, the VC limited partners also include institutional investors from around the world. With a portfolio of about 30 companies, the firm mainly invests in manufacturing, consumer goods, education, internet and petroleum & natural gas.In 2012, Chengwei and China Europe International Business School (CEIBS) jointly launched the $100m CEIBS-Chengwei Venture Capital Fund to invest in early- and growth-stage companies founded or managed by CEIBS alumni. The VC also seeks to support entrepreneurs to build sustainable businesses over a long period of time, acting as their long-term business partner.
One of the earliest and independent VC firms in China, Chengwei Capital was founded in Shanghai in 1999. It’s also the first and only evergreen fund in China.With Yale University Endowment as its largest investor, the VC limited partners also include institutional investors from around the world. With a portfolio of about 30 companies, the firm mainly invests in manufacturing, consumer goods, education, internet and petroleum & natural gas.In 2012, Chengwei and China Europe International Business School (CEIBS) jointly launched the $100m CEIBS-Chengwei Venture Capital Fund to invest in early- and growth-stage companies founded or managed by CEIBS alumni. The VC also seeks to support entrepreneurs to build sustainable businesses over a long period of time, acting as their long-term business partner.
Pesanlab is Indonesia’s first healthcare online platform to provide diagnostic laboratory and medical checkup bookings at affordable prices.
Pesanlab is Indonesia’s first healthcare online platform to provide diagnostic laboratory and medical checkup bookings at affordable prices.
Joe Zhou graduated from Beijing University of Technology in 1982 and worked five years as a lecturer at his alma mater. In 1987, he went to study in the US and obtained a master’s at the New Jersey Institute of Technology in 1989. He stayed in New Jersey and worked for five years at AT&T Bell Labs and its spin-off Lepton Inc.In 1995, Zhou returned to work in China as the VP of UTStarcom China until 1999 when he joined Softbank China Venture Capital as the head of its Beijing office. In October 2001, he became a partner at Softbank’s SAIF for five years. In 2007, he became a founding managing partner at Kleiner Perkins Caufield & Byers China. In April 2008, he co-founded Keytone Ventures as managing partner.
Joe Zhou graduated from Beijing University of Technology in 1982 and worked five years as a lecturer at his alma mater. In 1987, he went to study in the US and obtained a master’s at the New Jersey Institute of Technology in 1989. He stayed in New Jersey and worked for five years at AT&T Bell Labs and its spin-off Lepton Inc.In 1995, Zhou returned to work in China as the VP of UTStarcom China until 1999 when he joined Softbank China Venture Capital as the head of its Beijing office. In October 2001, he became a partner at Softbank’s SAIF for five years. In 2007, he became a founding managing partner at Kleiner Perkins Caufield & Byers China. In April 2008, he co-founded Keytone Ventures as managing partner.
Cambridge Enterprise Venture Partners
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
A Cambridge-based investor, founded in 2006, that exists to support spin-off companies created at the city’s university with an emphasis on social impact. It currently has 57 companies in its portfolio, almost entirely in the areas of life and physical sciences, which have, in total, raised over £2bn in further investment and grant funding.Its most recent investments include in the June 2021 £3m seed round of Gallium Nitride semiconductor engineering company Porotech and in the January 2021 $20m Series A round of quantum computing innovators Riverlane.
Besides helping medics to spot Covid-19 symptoms, BioMind is gearing up to launch its first EU-certified AI-powered diagnostic system for neurological diseases.
Besides helping medics to spot Covid-19 symptoms, BioMind is gearing up to launch its first EU-certified AI-powered diagnostic system for neurological diseases.
HigoSense launching advanced mobile device for self-triage and diagnosis, boosting telemedicine
The Polish medtech has developed a five-in-one diagnostic device for throat, ear, heart checks and more, with diagnosis in four minutes and compatible with diagnostic equipment
TMiRob's medical robots lighten the load of doctors and nurses in hospitals
The robots also reach an operating room three minutes faster than human nurses – that's more time for saving lives
MSMB: From university research to agritech ecosystem
The Indonesian startup is moving beyond sensors to build technologies for livestock tracking and fish farming
Virtual Bodyworks: VR psychotherapy to reduce crime and health issues
Applications created by the Barcelona-based startup could be used to track and influence human behavior
UpHill: Helping doctors put the latest research into practice
Born out of practitioners’ difficulty in keeping up with latest treatments and protocols, UpHill now includes guidance on Covid-19
Backed by pharmas, doctors, medtech startup DyCare is expanding fast across Europe
Its remote musculoskeletal rehabilitation and monitoring system sets to improve rehabilitation outcomes in an overtaxed sector
For your X-ray records, just check the cloud
A Chinese startup has built a digital medical image library on the cloud, bringing ease and cost savings to patients, doctors and hospitals countrywide
Icaria Medical's CardioSense: Cardiovascular pre-diagnosis in less than 60 seconds
Icaria Medical is seeking clinical validation and funding for its AI-based monitor, which measures blood pressure continuously and non-invasively
YITU takes smart healthcare to the next level
AI programs developed by this Chinese medtech startup provide more accurate diagnoses by reading medical images in conjunction with patients’ medical records
Napbox: Sleeping capsule mania takes off in Spain
Napbox's on-demand and intelligent cabins give privacy and connectivity in public spaces and offices
New Ventures Innovation: Prasetiya Mulya University takes on student entrepreneurship
To prepare a new generation of startup founders, Prasetiya Mulya University combines theoretical education with real-life exposure to the startup world
Lalibela Global-Networks: A mission to digitalize, move Africa's healthcare system to the cloud
This year’s Web Summit winner, Lalibela Global-Networks, is digitalizing Africa’s paper-based healthcare system in a low-cost, low-code way to save lives and make healthcare affordable
HeartGenetics: Using genetic data and AI to improve predictive health outcomes
Amid growing demand for personalized health and wellness solutions, the Portuguese startup is seeking €2m to expand to Germany and the UK
Brazilian edtech Blox seeks to upgrade university education across Latin America
Blox plans to raise over $1m in 2021 to expand across Brazil and Mexico, giving more choices to students to personalize degree programs with its AI curriculum management SaaS
Geometry Healthcare: Smart toilets that warn you if you are sick, or at risk
Using a biochip for urinalysis and offline health management services, Geometry Healthcare aims to differentiate itself in the smart toilet business
Sorry, we couldn’t find any matches for “Medical University of Warsaw”.
POPULAR DATABASE
